The earnings call reflects a strong financial performance with significant revenue growth, gross margin expansion, and a strategic enterprise agreement. Despite minor challenges with overhead absorption, the company's execution on cost reduction and cash management reinforces a positive outlook.

Company Guidance -

Q3 2025

In the second quarter of 2025, Outset Medical reported strong financial performance and raised its annual guidance. The company achieved revenue of $31.4 million, marking a 15% increase year-over-year, with strong Tablo console sales and consistent utilization contributing to the growth. Recurring revenue reached $22.5 million, up 11% from the previous year, driven by a 17% increase in consumable revenue. Non-GAAP gross margin expanded to 38.4%, an improvement of over one percentage point from the prior year. The company also reported a significant reduction in non-GAAP operating expenses, which fell by 19% to $25.4 million, and achieved a 46% reduction in net loss compared to the second quarter of 2024. Outset Medical ended the quarter with $187.4 million in cash and short-term investments and maintained its guidance to use less than $50 million in cash for the year. The company raised its revenue guidance for 2025 to a range of $122 million to $126 million and remains focused on its key priorities of growing console revenue, expanding gross margin, and driving towards profitability.

Revenue Growth

Revenue for the second quarter of 2025 was $31.4 million, representing a 15% increase over the second quarter of 2024.

Increase in Recurring Revenue

Recurring revenue from the sale of Tablo consumables and services reached $22.5 million, marking an 11% increase over the second quarter of 2024.

Gross Margin Expansion

Non-GAAP gross margin expanded to 38.4%, an increase of over 1 percentage point from last year, demonstrating progress towards a 50% gross margin.

Enterprise Agreement

Outset Medical closed a new enterprise agreement with one of the largest national health systems in the U.S., covering over 100 facilities with the potential to place hundreds of Tablo consoles.

Cost Reduction Achievements

The company reduced its non-GAAP operating expenses by 19% compared to the second quarter of 2024, resulting in a 36% reduction in non-GAAP operating loss.

Cash Management

Outset Medical used 60% less cash than in the prior year period and expects to use less than $50 million in cash in 2025, half of what was used in 2024.

Outset Medical (OM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OM Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.66 / -	-5.85	―	―	―
Aug 06, 2025	2025 (Q2)	-0.98 / -0.84	-7.05	88.09% (+6.21)	―
May 07, 2025	2025 (Q1)	-0.94 / -3.24	-8.55	62.11% (+5.31)	―
Feb 19, 2025	2024 (Q4)	-6.20 / -5.55	-8.85	37.29% (+3.30)	―
Nov 06, 2024	2024 (Q3)	-6.60 / -5.85	-10.65	45.07% (+4.80)	―
Aug 07, 2024	2024 (Q2)	-6.69 / -7.05	-10.35	31.88% (+3.30)	―
May 08, 2024	2024 (Q1)	-8.25 / -8.55	-10.8	20.83% (+2.25)	―
Feb 21, 2024	2023 (Q4)	-9.60 / -8.85	-10.65	16.90% (+1.80)	―
Nov 07, 2023	2023 (Q3)	-10.54 / -10.65	-10.5	-1.43% (-0.15)	―
Aug 02, 2023	2023 (Q2)	-11.32 / -10.35	-11.55	10.39% (+1.20)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OM Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$13.17	$14.18	+7.67%
May 07, 2025	$11.74	$15.88	+35.26%
Feb 19, 2025	$14.10	$14.40	+2.13%
Nov 06, 2024	$9.30	$11.64	+25.16%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Outset Medical, Inc. (OM) report earnings?

Outset Medical, Inc. (OM) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is Outset Medical, Inc. (OM) earnings time?

Outset Medical, Inc. (OM) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OM EPS forecast?

OM EPS forecast for the fiscal quarter 2025 (Q3) is -0.66.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing